PT656014E - Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica - Google Patents

Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica

Info

Publication number
PT656014E
PT656014E PT94911348T PT94911348T PT656014E PT 656014 E PT656014 E PT 656014E PT 94911348 T PT94911348 T PT 94911348T PT 94911348 T PT94911348 T PT 94911348T PT 656014 E PT656014 E PT 656014E
Authority
PT
Portugal
Prior art keywords
protein
purification
pharmaceutical composition
streptopes
estreptococks
Prior art date
Application number
PT94911348T
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of PT656014E publication Critical patent/PT656014E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT94911348T 1993-03-19 1994-03-21 Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica PT656014E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19

Publications (1)

Publication Number Publication Date
PT656014E true PT656014E (pt) 2003-09-30

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94911348T PT656014E (pt) 1993-03-19 1994-03-21 Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica

Country Status (18)

Country Link
US (1) US5869064A (pt)
EP (1) EP0656014B1 (pt)
JP (1) JP3976334B2 (pt)
KR (1) KR100331358B1 (pt)
CN (1) CN1046291C (pt)
AT (1) ATE240351T1 (pt)
CA (1) CA2158658A1 (pt)
DE (1) DE69432658T2 (pt)
DK (1) DK0656014T3 (pt)
ES (1) ES2194024T3 (pt)
HK (1) HK1008825A1 (pt)
HU (1) HU217582B (pt)
NZ (1) NZ263275A (pt)
PT (1) PT656014E (pt)
SG (1) SG47049A1 (pt)
SI (1) SI0656014T1 (pt)
WO (1) WO1994021685A1 (pt)
ZA (1) ZA941958B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
CN1733800A (zh) * 1998-12-22 2006-02-15 微科学有限公司 外表面蛋白质及其基因和用途
DK1141308T3 (da) * 1998-12-22 2007-06-04 Microscience Ltd Gruppe B streptococcus proteiner og deres anvendelse
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
NZ512574A (en) * 1998-12-23 2004-03-26 Iaf Biochem Int Novel streptococcus antigens useful as vaccines
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
CA2447750C (en) * 2001-05-31 2012-12-18 Fuso Pharmaceutical Industries, Ltd. Improved method for detecting and identifying causative microorganisms of infectious diseases
JPWO2002101037A1 (ja) * 2001-05-31 2005-04-07 扶桑薬品工業株式会社 食細胞機能の評価方法およびその利用
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
US20070014841A1 (en) * 2005-02-08 2007-01-18 Denis Martin Pharmaceutical compositions
EP2144924B1 (en) 2007-04-16 2016-05-11 MinervaX Aps Fusion protein vaccine
CN108135992A (zh) 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
WO2017114655A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
CA3066020A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
MX2022006054A (es) 2019-11-22 2022-06-24 Glaxosmithkline Biologicals Sa Dosificacion y administracion de una vacuna de glucoconjugados de sacaridos bacterianos.
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン, エルビン 新規な遺伝子及びIgA結合蛋白質の製造方法

Also Published As

Publication number Publication date
DE69432658T2 (de) 2004-04-08
NZ263275A (en) 1997-07-27
KR960701096A (ko) 1996-02-24
HU9501993D0 (en) 1995-08-28
US5869064A (en) 1999-02-09
AU681130B2 (en) 1997-08-21
WO1994021685A1 (en) 1994-09-29
DE69432658D1 (de) 2003-06-18
CA2158658A1 (en) 1994-09-29
HU217582B (hu) 2000-02-28
EP0656014B1 (en) 2003-05-14
EP0656014A1 (en) 1995-06-07
AU6389194A (en) 1994-10-11
KR100331358B1 (ko) 2002-08-13
SI0656014T1 (en) 2003-12-31
CN1119442A (zh) 1996-03-27
ATE240351T1 (de) 2003-05-15
JPH09500092A (ja) 1997-01-07
JP3976334B2 (ja) 2007-09-19
DK0656014T3 (da) 2003-08-11
ES2194024T3 (es) 2003-11-16
HUT72841A (en) 1996-05-28
ZA941958B (en) 1995-01-27
HK1008825A1 (en) 1999-05-21
CN1046291C (zh) 1999-11-10
SG47049A1 (en) 1998-03-20

Similar Documents

Publication Publication Date Title
PT656014E (pt) Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
BR9710968A (pt) Antìgenos de célula b humana; reagentes correlatos
DK0994728T3 (da) Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
NO20006191L (no) Vaksine
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
NO944245D0 (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
SE8505458D0 (sv) Bakteriofager som igenkennings- och identifieringsmedel
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
NO922421L (no) Collagenbindende protein, samt fremstilling derav
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof
BR9713111A (pt) Processo de duas etapas para a produção de itens moldados de poliuretano semi-rìgido.
ATE342977T1 (de) Nukleinsäure, die für polypeptide kodieren die eine mutt-domäne enthalten
BR9910624A (pt) Fragmentaçã0 do peptìdeo, proteìna de fusão, fragmento de ácido nucleico, ácido nuicleico, vetor, processo para preparar proteìnas de fusão, uso de um fragmento de proteìna ou de um fragmento de ácido nucleico, e, processos para preparar fragmentos de proteìna e para detectar proteìnas.
BR8906960A (pt) Processo para obtencao de peptidio,molecula dna,composicao farmaceutica,processo para utilizacao de peptidio,intermediario de peptidio-resina e reagente de diagnostico
IL151564A0 (en) Potassium channel proteins
BR0214288A (pt) Anticorpos monoclonais especìficos para tumor, ácidos nucléicos que codificam tais anticorpos e método para redução de proliferação de células neoplásicas
SE9301207D0 (sv) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition